ProtekAI Overview

  • Founded
  • 2010

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

ProtekAI General Information


Developer of proteins intended for the life science industry. The company is engaged in the research and development of a de novo fluorescent protein extracted from the marine organism Physalia (Portuguese man-of-war), enabling the medical and scientific community to support diagnostic and research applications.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 7192 Kalanianaole Highway
  • Suite A143a, Number 255
  • Honolulu, HI 96825
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ProtekAI Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Jun-2018 00000 Completed Out of Business
2. Accelerator/Incubator 00000 Completed Generating Revenue
1. Early Stage VC 07-Dec-2010 $100K $100K 00000 Completed Generating Revenue
To view ProtekAI’s complete valuation and funding history, request access »

ProtekAI Cap Table

Stock # of Shares
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 0,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000
To view ProtekAI’s complete cap table history, request access »